Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Yan JJ, Guo SS, Lin DF, Liu LT, Liu SL, Xiao BB, Yang JH, Wen DX, Yang ZC, Liang YJ, Tang QN, Lin C, Li XY, Sun XS, Li JB, Tang LQ, Chen QY, Mai HQ. Yan JJ, et al. Among authors: wen dx. Radiother Oncol. 2021 Jul;160:9-17. doi: 10.1016/j.radonc.2021.03.040. Epub 2021 Apr 9. Radiother Oncol. 2021. PMID: 33839205 Free article.
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Tang QN, Qiu HZ, Sun XQ, Guo SS, Liu LT, Wen YF, Liu SL, Xie HJ, Liang YJ, Sun XS, Li XY, Yan JJ, Yang JH, Wen DX, Guo L, Tang LQ, Chen QY, Mai HQ. Tang QN, et al. Among authors: wen dx, wen yf. Ann Transl Med. 2021 Apr;9(7):532. doi: 10.21037/atm-20-6493. Ann Transl Med. 2021. PMID: 33987230 Free PMC article.
Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.
Liang YJ, Wen DX, Luo MJ, Tang LQ, Guo SS, Wang P, Chen QY, Liu LT, Mai HQ. Liang YJ, et al. Among authors: wen dx. Eur J Cancer. 2021 Dec;159:133-143. doi: 10.1016/j.ejca.2021.09.045. Epub 2021 Nov 4. Eur J Cancer. 2021. PMID: 34743068
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
Li XY, Luo DH, Guo L, Mo HY, Sun R, Guo SS, Liu LT, Yang ZC, Yang JH, Qiu F, Sun XS, Wang P, Liu Q, Li JB, Tang QN, Lin C, Yang Q, Liu SL, Liang YJ, Jia GD, Wen DX, Guo CY, Yan JJ, Zhao C, Chen QY, Tang LQ, Mai HQ. Li XY, et al. Among authors: wen dx. J Clin Oncol. 2022 Apr 10;40(11):1163-1173. doi: 10.1200/JCO.21.01467. Epub 2022 Jan 6. J Clin Oncol. 2022. PMID: 34990291 Clinical Trial.
25 results